Dr. Randall F. Holcombe, chief medical officer for cancer in the Mount Sinai Health System in New York City, has been chosen as the next director of the University of Hawaii Cancer Center.
His selection is subject to final approval by the UH Board of Regents at its Thursday meeting.
Randall F. Holcombe
Holcombe has spent more than 25 years in academic medicine. According to a UH press release, he is also “a researcher, with more than 100 peer-reviewed publications, a clinician and an effective administrative leader.”
Prior to joining Mount Sinai, Holcombe served as the division chief of hematology/oncology for 13 years at the University of California Irvine. He graduated from Duke University and the University of Medicine and Dentistry of New Jersey‐NJ Medical School.
Jerris Hedges, dean of the University of Hawaii’s John A. Burns School of Medicine, has been serving as the cancer center’s interim director since the resignation in November 2014 of Michele Carbone.
At the time of Carbone’s resignation, the center faced an annual budget deficit of about $10 million.
University of Hawaii Cancer Center.
PF Bentley/Civil Beat
Stay Up To Date On The Coronavirus And Other Hawaii Issues